Logo image of FLWS

1-800-FLOWERS.COM INC-CL A (FLWS) Stock Fundamental Analysis

NASDAQ:FLWS - Nasdaq - US68243Q1067 - Common Stock - Currency: USD

4.49  -0.16 (-3.44%)

After market: 4.5 +0.01 (+0.22%)

Fundamental Rating

3

Taking everything into account, FLWS scores 3 out of 10 in our fundamental rating. FLWS was compared to 121 industry peers in the Specialty Retail industry. FLWS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FLWS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

FLWS had negative earnings in the past year.
FLWS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: FLWS reported negative net income in multiple years.
In the past 5 years FLWS always reported a positive cash flow from operatings.
FLWS Yearly Net Income VS EBIT VS OCF VS FCFFLWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a Return On Assets value of -0.67%, FLWS is not doing good in the industry: 61.16% of the companies in the same industry are doing better.
FLWS has a Return On Equity (-1.54%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.67%
ROE -1.54%
ROIC N/A
ROA(3y)-0.71%
ROA(5y)3.3%
ROE(3y)-1.66%
ROE(5y)6.62%
ROIC(3y)N/A
ROIC(5y)N/A
FLWS Yearly ROA, ROE, ROICFLWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

FLWS's Operating Margin has declined in the last couple of years.
The Gross Margin of FLWS (40.11%) is better than 61.16% of its industry peers.
FLWS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FLWS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.11%
OM growth 3Y-48.39%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-0.98%
FLWS Yearly Profit, Operating, Gross MarginsFLWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

FLWS does not have a ROIC to compare to the WACC, probably because it is not profitable.
FLWS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FLWS has been reduced compared to 5 years ago.
FLWS has a better debt/assets ratio than last year.
FLWS Yearly Shares OutstandingFLWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
FLWS Yearly Total Debt VS Total AssetsFLWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.32 indicates that FLWS is not a great score, but indicates only limited risk for bankruptcy at the moment.
FLWS has a Altman-Z score (2.32) which is in line with its industry peers.
A Debt/Equity ratio of 0.32 indicates that FLWS is not too dependend on debt financing.
The Debt to Equity ratio of FLWS (0.32) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACCN/A
WACC10.26%
FLWS Yearly LT Debt VS Equity VS FCFFLWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

FLWS has a Current Ratio of 1.51. This is a normal value and indicates that FLWS is financially healthy and should not expect problems in meeting its short term obligations.
FLWS's Current ratio of 1.51 is fine compared to the rest of the industry. FLWS outperforms 60.33% of its industry peers.
FLWS has a Quick Ratio of 1.03. This is a normal value and indicates that FLWS is financially healthy and should not expect problems in meeting its short term obligations.
FLWS's Quick ratio of 1.03 is fine compared to the rest of the industry. FLWS outperforms 73.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.03
FLWS Yearly Current Assets VS Current LiabilitesFLWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

The earnings per share for FLWS have decreased strongly by -1247.83% in the last year.
The earnings per share for FLWS have been decreasing by -17.07% on average. This is quite bad
The Revenue has decreased by -9.24% in the past year.
The Revenue has been growing slightly by 7.96% on average over the past years.
EPS 1Y (TTM)-1247.83%
EPS 3Y-52.28%
EPS 5Y-17.07%
EPS Q2Q%-900%
Revenue 1Y (TTM)-9.24%
Revenue growth 3Y-4.79%
Revenue growth 5Y7.96%
Sales Q2Q%-12.64%

3.2 Future

The Earnings Per Share is expected to grow by 0.66% on average over the next years.
FLWS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.86% yearly.
EPS Next Y-185%
EPS Next 2Y7.12%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.86%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FLWS Yearly Revenue VS EstimatesFLWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
FLWS Yearly EPS VS EstimatesFLWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

FLWS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 19.56 indicates a rather expensive valuation of FLWS.
FLWS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FLWS is cheaper than 60.33% of the companies in the same industry.
FLWS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 19.56
FLWS Price Earnings VS Forward Price EarningsFLWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FLWS indicates a rather cheap valuation: FLWS is cheaper than 82.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.67
FLWS Per share dataFLWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.12%
EPS Next 3Y0.66%

0

5. Dividend

5.1 Amount

FLWS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

1-800-FLOWERS.COM INC-CL A

NASDAQ:FLWS (5/21/2025, 8:00:00 PM)

After market: 4.5 +0.01 (+0.22%)

4.49

-0.16 (-3.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-27 2025-08-27/amc
Inst Owners88.8%
Inst Owner Change7.92%
Ins Owners5.67%
Ins Owner Change2.94%
Market Cap285.56M
Analysts82.5
Price Target10.88 (142.32%)
Short Float %36.87%
Short Ratio10.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.14%
Min EPS beat(2)-17.61%
Max EPS beat(2)3.33%
EPS beat(4)1
Avg EPS beat(4)-10.25%
Min EPS beat(4)-17.61%
Max EPS beat(4)3.33%
EPS beat(8)5
Avg EPS beat(8)1.88%
EPS beat(12)7
Avg EPS beat(12)0.59%
EPS beat(16)10
Avg EPS beat(16)7.99%
Revenue beat(2)0
Avg Revenue beat(2)-5.25%
Min Revenue beat(2)-5.34%
Max Revenue beat(2)-5.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.77%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-3.12%
Revenue beat(12)2
Avg Revenue beat(12)-2.79%
Revenue beat(16)5
Avg Revenue beat(16)-1.41%
PT rev (1m)8.02%
PT rev (3m)-1.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.59%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-51.52%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.56
P/S 0.16
P/FCF N/A
P/OCF 8.51
P/B 0.58
P/tB 1.28
EV/EBITDA 4.67
EPS(TTM)-2.64
EYN/A
EPS(NY)0.23
Fwd EY5.11%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.53
OCFY11.75%
SpS27.64
BVpS7.78
TBVpS3.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -1.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.11%
FCFM N/A
ROA(3y)-0.71%
ROA(5y)3.3%
ROE(3y)-1.66%
ROE(5y)6.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.61%
ROCE(5y)8.55%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.39%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-0.98%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 3.76
Cap/Depr 81.85%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion 80.01%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.03
Altman-Z 2.32
F-Score6
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)96.72%
Cap/Depr(5y)105.36%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1247.83%
EPS 3Y-52.28%
EPS 5Y-17.07%
EPS Q2Q%-900%
EPS Next Y-185%
EPS Next 2Y7.12%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.24%
Revenue growth 3Y-4.79%
Revenue growth 5Y7.96%
Sales Q2Q%-12.64%
Revenue Next Year-5.69%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.86%
Revenue Next 5YN/A
EBIT growth 1Y-139.74%
EBIT growth 3Y-50.86%
EBIT growth 5Y-17.07%
EBIT Next Year327.29%
EBIT Next 3Y91.28%
EBIT Next 5YN/A
FCF growth 1Y76.85%
FCF growth 3Y-21.85%
FCF growth 5Y4.38%
OCF growth 1Y156.08%
OCF growth 3Y-18.16%
OCF growth 5Y4%